Fresenius SE

Fresenius successfully raises € 138 million via a tap to its 2006 Senior Notes
Fresenius today announced that it has successfully placed a tap to its 2006 Senior Notes by its subsidiary, Fresenius Finance B.V. >>>

Fresenius announces Senior Notes Offering
Fresenius today announced its intention to issue Senior Unsecured Notes through its subsidiary Fresenius Finance B.V., subject to market conditions. >>>

New Renal Pharma Website from Fresenius Medical Care – Interactive Online Training in Bone Metabolism
Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis services and products, has launched a new website focusing on dialysis medications (“renal pharmaceuticals”). At www.fmc-renalpharma.com, doctors as well as patients and the interested public are now able to find information about Fresenius Medical Care’s pharmaceutical expertise. >>>

Fresenius Medical Care announces completion of government investigation
Bad Homburg, Germany – Fresenius Medical Care AG & Co. KGaA (”FME”), the world’s largest provider of Dialysis Services and Products, today announced, that the United States Attorney's Office for the Eastern District of New York (Brooklyn) has completed its investigation of Fresenius Medical Care's North American subsidiaries. >>>

Fresenius Medical Care Reports Strong Start for 2009 and Confirms Outlook for Full Year (for additional tables see PDF-file)
Fresenius Medical Care AG & Co. KGaA (“the Company” or “FMC AG & Co. KGaA”), the world’s largest provider of dialysis products and services, today announced its results for the first quarter of 2009. >>>